Evolent Health (EVH) Operating Income (2015 - 2026)

Evolent Health's Operating Income history runs 12 years deep, the most recent figure standing at -$10.6 million for Q1 2026.

• In Q1 2026, Operating Income fell 553.45% year-over-year to -$10.6 million; the TTM figure through Mar 2026 stood at -$419.1 million (down 1360.43% YoY), while the FY2025 annual figure was -$410.1 million, down 913.06% from the prior year.
• Operating Income was -$10.6 million for Q1 2026 at Evolent Health, up from -$408.2 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of $13.0 million in Q3 2022 to a low of -$408.2 million in Q4 2025.
• Historically, Operating Income has averaged -$31.1 million across 5 years, with a median of -$10.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Operating Income surged 296.79% in 2022, then tumbled 2095.26% in 2025.
• A 5-year view of Operating Income shows it stood at -$1.9 million in 2022, then slumped by 1036.85% to -$21.3 million in 2023, then increased by 12.9% to -$18.6 million in 2024, then sank by 2095.26% to -$408.2 million in 2025, then soared by 97.4% to -$10.6 million in 2026.
• The last three Operating Income figures came in at -$10.6 million (Q1 2026), -$408.2 million (Q4 2025), and $886000.0 (Q3 2025), per Business Quant data.